Education, Science, Technology, Innovation and Life
Open Access
Sign In

Progress in research on mechanism of saponins in treating osteoarthritis

Download as PDF

DOI: 10.23977/medcm.2023.050309 | Downloads: 17 | Views: 593

Author(s)

Qi He 1,2, Meng Jin 1,2, Lei Huang 1,2, Jianbin Ma 2, Rui Zhang 2

Affiliation(s)

1 Shaanxi University of Chinese Medicine, Xianyang, Shaanxi, 712046, China
2 Honghui Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi, 710054, China

Corresponding Author

Rui Zhang

ABSTRACT

Osteoarthritis (OA) is a degenerative joint disease caused by a variety of factors, which is highly prevalent in the elderly population and is mainly characterized by articular cartilage degeneration and surrounding bone regeneration, with clinical manifestations of repeated joint swelling, pain, stiffness and joint deformity at a later stage. OA is a chronic disease that gives elderly patients and their relatives many life inconveniences and economic pressures. According to the practicability and effectiveness of treatment in elderly patients, the advantages of traditional Chinese medicine stand out. At present, the active ingredients of traditional Chinese medicine are divided into saponins, saponins, alkaloids and polyphenols, of which saponins are the main active ingredients of traditional Chinese medicine. This paper summarizes the research results and progress of icariin, ginsenoside Rg1, astragaloside IV, clematis saponins and other saponins in the treatment of osteoarthritis.

KEYWORDS

Oteoarthritis, active ingredients of saponins, mechanism of action, research progress

CITE THIS PAPER

Qi He, Meng Jin, Lei Huang, Jianbin Ma, Rui Zhang, Progress in research on mechanism of saponins in treating osteoarthritis. MEDS Chinese Medicine (2023) Vol. 5: 64-68. DOI: http://dx.doi.org/10.23977/medcm.2023.050309.

REFERENCES

[1] Peng Kai, Wang Xiaomeng, Cao Weixia, et al. Interpretation of 2018 Osteoarthritis Diagnosis and Treatment Guidelines [J]. Journal of Hebei Medical University, 2018, 39 (11): 1241-1243.
[2] Joint Surgery Group of Chinese Orthopaedic Association, Osteoarthritis Group of Chinese Orthopaedic Association, Osteoarthritis Group of Chinese Orthopaedic Surgeon Association, National Clinical Research Center for Geriatric Diseases (Xiangya Hospital), Editorial Office of Chinese Orthopaedic Journal. Guidelines for the Diagnosis and Treatment of Osteoarthritis (2021 Edition) [J]. Chinese Orthopaedic Journal, 2021, 41 (18): 1297-1314.
[3] Lu Zhiming, Du Yufeng, Cheng Xiaoling, et al. Progress in the mechanism of action of traditional Chinese medicine monomers against articular cartilage degeneration in osteoarthritis [J]. Chinese Medicinal Materials, 41, 10: 2485-2490.
[4] Chen Song. Progress in the pathogenesis of osteoarthritis [J]. World Latest Medicine Information, 2019, 19 (7): 27-28. 
[5] Abramson SB. Niteic oxide in inflammation and pain associated with osteoarthritis [J]. Arthritis Res Ther, 2008, 10 (2): 2-10.
[6] Huang Di Nei Jing Su Wen [M]. Beijing: New World Press, 2013.
[7] Li Satisfied, Lou Yuqi. Source and Flow of Gu Bi and Review of Relevant Historical Literature [J]. Rheumatism and Arthritis, 2014, 3 (12): 59-68.
[8] Wang Xiaoxue, Wang Ping, Yao Pengyu, et al. Study on syndrome differentiation and staging treatment of osteoarthritis [N]. Journal of Liaoning University of Traditional Chinese Medicine, 2021-06-25.
[9] Lu Zhiming, Du Yufeng, Cheng Xiaoling, et al. Progress in the mechanism of action of traditional Chinese medicine monomers against articular cartilage degeneration in osteoarthritis [J]. Chinese Medicinal Materials, 2018, 41 (10): 2485-2490.
[10] Wang Xiaobo, Zhang Juntao, Liu Aifeng, et al. Progress in the mechanism of icariin in promoting cartilage repair in osteoarthritis [J]. Chinese Journal of Traditional Chinese Medicine, 2021, 39 (5): 171-174.
[11] Sun Haifeng, Yang Maowei, Shi Yongchen, et al. Mechanism of icariin on TDP-43-mediated osteoarthritic chondrocyte lesions [J]. World Chinese Medicine, 2019, 14 (7): 1672-1676.
[12] Shi Jiyuan, Jile Le, Wu Shixun, et al. Icariin attenuates osteoarthritis by inhibiting the nlrp3 inflammasome and caspase-1 pathway [J] .2021, 16 (18): 2706-2713.
[13] Ma Chunhui, Cai Guoping, Yan Zuoqin, et al. Expression of type II collagen in osteoarthritic chondrocytes [J]. Fudan University Journal (Medical Edition), 2009, 06:734-736.
[14] Zhang Yeyong, Cheng Wendan, Chen Zefeng, et al. Effect of ginsenoside Rg1 on the expression of type II collagen in chondrocytes [J]. Chinese Journal of Tissue Engineering Research, 2013, 1711:1917-1924.
[15] Gu Yuanyang, Yan Peijun. Study on the protective mechanism of ginsenoside Rg1 on IL-1β-induced degradation of human knee chondrocytes [J]. Journal of Nanjing University of Traditional Chinese Medicine, 2018, 3404: 357-360.
[16] Duan Chao. Experimental study on ginsenoside Rg1 in the prevention and treatment of knee osteoarthritis in rabbits [D]. Hubei University of Traditional Chinese Medicine, 2016.
[17] Wang Wei. Experimental study on the regulation of matrix metalloproteinase-13 by ginsenoside Rb1 through Notch signaling pathway in the prevention and treatment of osteoarthritis [D]. Chongqing Medical University, 2015.
[18] Zhang Ruihua, Zhang Jingwen, Liu Ling, et al. Pharmacological action and clinical application of Astragalus membranaceus and its effective components [J]. Shaanxi Traditional Chinese Medicine, 2021, 8 (42): 1138-1146.
[19] Xia Pengfei, Yan Chunlu, An Fangyu, et al. Effect of selenium-enriched astragaloside on proliferation of degenerated chondrocytes in rats and its mechanism [J]. Chinese Journal of Clinical Pharmacology, 2020, 06:639-642.
[20] Yan Chunlu, Li Shenghua, An Fangyu, et al. Study on the Regulatory Mechanism of Selenium-enriched Astragaloside on Wnt/β-catenin Signaling Pathway in Rat Degenerative Chondrocytes [J]. Chinese Journal of Clinical Pharmacology, 2018, 10:1210-1213.
[21] Meng Xiangqi, Huang Guicheng, Hui Qianhua, et al. Effect of astragaloside IV on MMP-1 and MMP-3 mRNA expression in degenerated chondrocytes of human knee osteoarthritis [J]. Journal of Liaoning University of Traditional Chinese Medicine, 202, 14 (7): 88-90.
[22] Li Shizhen (Ming). Compendium of Materia Medica [M]. Beijing: Beijing Press, 2007:178-180.
[23] Yan Shanlin, Chen Lijia, Li Zhengxiang, et al. Progress in Chemical Composition and Biological Activity of Clematis chinensis [J]. Tianjin Pharmacy, 2016, 28 (2): 48-52.
[24] Xia Lunzhu, Xu Xianxiang, Zhang Rui. Study on anti-inflammatory effect of total saponins of Clematis chinensis on adjuvant arthritis in rats [J]. Anhui Medicine, 2009, 13 (4): 363-365.

Downloads: 5394
Visits: 241009

Sponsors, Associates, and Links


All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.